Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

20drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Akk ×

Akk

This drug is selected. Its supporting articles are shown below.

AKK3

Articles mentioning Akk

3 articles · page 1 of 1

494 Akkermansia muciniphila reprograms immunosuppressive microenvironment via efferocytosis inhibition to sensitize anti-PD-1 therapy in MSS colorectal cancer: phase I trial

jitc · abstract · 2025-11-04 · 9 matching annotations

88.9%

Akk PD-1 inhibitors West China Hospital of Sichuan University Institutional Review Board CRC immunotherapy ClinicalTrials.gov

…and systemic immune profile dynamics.Results In animal studies, Akk suppressed tumor-associated macrophages (TAMs) efferocytosis. T…

493 Akkermansia muciniphila reprograms immunosuppressive microenvironment via efferocytosis inhibition to sensitize anti-PD-1 therapy in MSS colorectal cancer: phase I trial

jitc · abstract · 2025-11-04 · 7 matching annotations

85.6%

Akk PD-1 inhibitors West China Hospital of Sichuan University Institutional Review Board CRC immunotherapy ClinicalTrials.gov MSS CRC

…ts with treatment-refractory advanced MSS CRC who received oral Akk probiotic capsules combined with PD-1 inhibitors, evaluating sa…

Enhancing immunotherapy efficacy in NSCLC through the combined use of phenelzine and Akkermansia muciniphila to regulate gut microbial metabolite 5-HIAA

jitc · abstract · 2025-09-10 · 4 matching annotations

85.8%

phenelzine Akkermansia muciniphila Phe AKK 5-HIAA non-small cell lung cancer NSCLC immunotherapy

…ect of 5-HIAA on tumor-infiltrating lymphocytes. The effects of phenelzine (Phe) and Akkermansia muciniphila (AKK) on 5-HIAA synthesis, an…